Silicon Valley has shaped one technology tycoon after another. From jobs to musk, the CEOs of these technology giants seem to have the same thing in common. They are all eccentric, energetic, whimsical and charismatic.
Silicon Valley now has a third biotech giant, Theranos, trying to change the world by changing the way we test blood every day. Founder Elizabeth dropped out of Stanford to start her own business, trying to create a portable blood-testing machine. She named the machine Edison, which, in her words, was the product of numerous failures and finally success. However, even though she has raised more than 100 million yuan and is supported by the government and military bosses, she cannot hide the stagnation of research. To boost financing, she sold an office building and expanded into a blood-testing station. However, the results of the blood-testing stations differed significantly from those of other research stations.
Her business turned out to be riddled with deceit and lies, the portable blood-testing machine never worked, and most of the results were picked up by the large detectors already on the market.
What we have seen, Theranos has been using commercial secrets as an excuse to cover up the structure and principles of edison, while evading supervision. In fact, this kind of trick is not the first time that it has been staged. Both Musk and Jobs have had extreme operations that almost collapsed. The trick to maintain the company is actually the same as Theranos. The difference is that they succeeded. But to trace the origin of this trick, it is the origin of the name of edison, the inventor of Edison, his light bulb was actually already on the market before the experiment was completed, although the filament at that time would break in less than 10 hours after lighting, Edison Using the time gained, a viable filament was successfully found.
Investors in Silicon Valley seem to be more and more convinced. Just give your money to someone with passion and believe that they can change the world, and you will be rewarded. The cases of Jobs and Musk, coupled with the media's rendering, have made the image of a paranoid entrepreneur deeply rooted in the hearts of the people. Investors listen to the stories of entrepreneurs like laymen, but the rationality of investment theory is diluted. The people's tolerance for what is morally right magnifies the loopholes in the regulatory process. Are we being too lenient with entrepreneurs? Perhaps tolerance of genius is needed, but if the health of consumers is required to pay for their trial and error, it is not a need for tolerance to be justified.
View more about The Inventor: Out for Blood in Silicon Valley reviews
